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Abstract
Background: Two species of Ganoderma, G. sinense and G. lucidum, are used as Lingzhi in China. Howerver, the
content of triterpenoids and polysaccharides, main actives compounds, are significant different, though the extracts
of both G. lucidum and G. sinense have antitumoral proliferation effect. It is suspected that other compounds
contribute to their antitumoral activity. Sterols and fatty acids have obvious bioactivity. Therefore, determination
and comparison of sterols and fatty acids is helpful to elucidate the active components of Lingzhi.
Results: Ergosterol, a specific component of fungal cell membrane, was rich in G. lucidum and G. sinense. But its
content in G. lucidum (median content 705.0 μg·g
-1, range 189.1-1453.3 μg·g
-1, n = 19) was much higher than that
in G. sinense (median content 80.1 μg·g
-1, range 16.0-409.8 μg·g
-1, n = 13). Hierarchical clustering analysis based on
the content of ergosterol showed that 32 tested samples of Ganoderma were grouped into two main clusters, G.
lucidum and G. sinense. Hierarchical clustering analysis based on the contents of ten fatty acids showed that two
species of Ganoderma had no significant difference though two groups were also obtained. The similarity of two
species of Ganoderma in fatty acids may be related to their antitumoral proliferation effect.
Conclusions: The content of ergosterol is much higher in G. lucidum than in G. sinense. Palmitic acid, linoleic acid,
oleic acid, stearic acid are main fatty acids in Ganoderma and their content had no significant difference between
G. lucidum and G. sinense, which may contribute to their antitumoral proliferation effect.
Background
Ganoderma (Lingzhi in Chinese) is a genus of well-
known medicinal mushrooms with multiple benefits to
human health. So far, more than 120 species of Gano-
derma have been reported in the world, 98 species of
which could be found in China [1]. However, only two
species of Ganoderma (Figure 1), G. lucidum (Leyss.ex
Fr.) Karst. and G. sinense Zhao, Xu et Zhang, are docu-
mented as Lingzhi in Chinese Pharmacopoeia (2010) [2].
Modern studies have revealed that Lingzhi contain a
variety of bioactive ingredients, including triterpenoids,
polysaccharides, sterols, fatty acids, nucleosides and
alkaloids [3], and possess multiple pharmacological
activities, such as antitumor [1,4], immunomodulation
[5,6], anti-inflammatory [7], antiviral [8], anti-aging [9]
and anti-diabetic [10] effects. It is usually considered
that triterpenoids and polysaccharides are the main
active components in Lingzhi [3]. However, our previous
study has revealed that the contents of triterpenes are
significantly different between G. lucidum and G. sinense
[11]. Actually, little or no triterpene was detected in G.
sinense [1,11,12]. It is very interesting that ethanol
extracts of both G. lucidum and G. sinense,a tt h es a m e
cytotoxicity concentration, have similar antitumoral pro-
liferation effect through both apoptosis pathway and cell
cycle arrest effect [1], which indicates that some other
compounds may contribute to their activity besides tri-
terpenoids and polysaccharides.
To date, several sterols and fatty acids, which have sig-
nificant bio-functions in fungi [13,14], were separated or
identified from Ganoderma [7,8,15-17]. Ergosterol and its
analogues contained in Ganoderma had multiple pharma-
cological effects such as anti-HIV-1 [7], anti-complement
[8], anti-aging [9] activities, and protecting cerebral corti-
cal neurons from hypoxia/reoxygenation injury [18]. On
the other hand, free fatty acids (FFAs) are not only essen-
tial nutritional ingredients but also significant to many cel-
lular functions through receptors of FFAs [19]. Especially,
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© 2010 Guang-ping et allong chain fatty acids in the spores of G. lucidum could
triggers tumor cell death through induction of apoptosis
[20]. Therefore, analysis of sterols and fatty acids in two
species of Ganoderma is not only important for evaluation
of their quality but also beneficial to the elucidation of
their pharmacological activities.
Up to date, TLC [21-23], HPLC [11,24-28], GC
[16,29-31], MEKC [32] have been developed for analysis
of triterpenoids [11,21-24,26,27], polysaccharides
[25,28-31] and nucleosides [32] in Ganoderma.H o w -
ever, few researches focus on the analysis of sterols or
fatty acids in Ganoderma [15,16,33]. In present study,
ergosterol and ten free fatty acids, including lauric acid
(C12:0), myristic acid (C14:0), pentadecanoic acid
(C15:0), palmitic acid (C16:0, PA), palmitoleic acid
(C16:1), stearic acid (C18:0, SA), oleic acid (C18:1, OA),
linoleic acid (C18:2, LoA), docosanoic acid (C22:0) and
lignoceric acid (C24:0), in two species of Ganoderma
were determined by using pressurized liquid extraction
(PLE) and GC-MS analysis after one-step TMS derivati-
zation. The contents of the free sterol and fatty acids in
G. lucidum and G. sinense were also compared.
Experimental
Materials and chemicals
Lauric acid (C12:0, dodecanoic acid), myristic acid
(C14:0, tetradecanoic acid), pentadecanoic acid (C15:0),
palmitic acid (C16:0, hexadecanoic acid), palmitoleic
acid (C16:1, (Z)-hexadec-9-enoic acid), stearic acid
(C18:0, octadecanoic acid), oleic acid (C18:1, (Z)-octa-
dec-9-enoic acid), linoleic acid (C18:2, (9Z,12Z)-octa-
deca-9,12-dienoic acid), docosanoic acid (C22:0),
lignoceric acid (C24:0, tetracosanoic acid) and ergosterol
were purchased from Sigma (St. Louis, MO, USA). Pet-
roleum ether (60-90°C) and n-hexane were purchased
from Merck (Darmstadt, Germany). Derivatization
reagent BSTFA (N, O-bis (trimethylsilyl) trifluoroaceta-
mide) containing 1% TMCS (trimethylchlorosilane) was
purchased from Supelco (St. Louis, MO, USA). Reagents
not mentioned here were from standard sources. The
materials of Ganoderma were obtained from different
locations in China (Table 1). Voucher specimens of
these samples were deposited at the Institute of Chinese
Medical Sciences, University of Macau, Macao, China.
Sample preparation
Pressurized liquid extractions were performed on a Dio-
nex ASE 200 (Dionex Corp., Sunnyvale, CA, USA) sys-
tem. In brief, 0.2 g powder of Ganoderma were mixed
with diatomaceous earth in a proportion (1:1) and
placed into an 11 ml stainless steel extraction cells,
respectively. The extraction with petroleum ether was
performed under optimized conditions: temperature,
160°C; static extraction time, 10 min; pressure, 1500 psi;
flush volume, 40%; static cycle 1 and one for the num-
ber of extraction. The extract (approximate 15 mL) was
dried under N2 (Organomation Associates, Inc., Berlin,
MA, USA), then 100 μL derivatization agent (BSTFA)
and 400 μL n- h e x a n ew e r ea d d e dt ot h er e s i d u ea n d
reacted at 70°C for 30 min. The derivative mixture was
1cm
B A
1cm
Figure 1 Raw materials of (A) Ganoderma lucidum and (B)
Ganoderma sinense.
Table 1 Summary for the tested samples of Ganoderma
No. Code Samples Sources
1 GL-1 G. lucidum Dabieshan, Anhui, China
2 GL-2 G. lucidum Dabieshan, Anhui, China
3 GL-3 G. lucidum Jinzhai, Anhui, China
4 GL-4 G. lucidum Jiaxiang, Shandong, China
5 GL-5 G. lucidum Guanxian, Shandong, China
6 GL-6 G. lucidum Jingzhou, Hunan, China
7 GL-7 G. lucidum Jingning, Zhejiang, China
8 GL-8 G. lucidum Liangshan, Shandong, China
9 GL-9 G. lucidum Emei, Sichuan, China
10 GL-10 G. lucidum Emei, Sichuan, China
11 GL-11 G. lucidum Jiaxiang, Shandong, China
12 GL-12 G. lucidum Beijing, China
13 GL-13 G. lucidum Dabieshan, Anhui, China
14 GL-14 G. lucidum Jinzhai, Anhui, China
15 GL-15 G. lucidum Anshun, Guizhou, China
16 GL-16 G. lucidum Guanxian, Shandong, China
17 GL-17 G. lucidum Dabieshan, Anhui, China
18 GL-18 G. lucidum Emei, Sichuan, China
19 GL-19 G. lucidum Anshun, Guizhou, China
20 GS-1 G. sinense Dabieshan, Anhui, China
21 GS-2 G. sinense Jinzhai, Anhui, China
22 GS-3 G. sinense Dabieshan, Anhui, China
23 GS-4 G. sinense Dabieshan, Anhui, China
24 GS-5 G. sinense Pingguo, Guangxi, China
25 GS-6 G. sinense Liangshan, Shandong, China
26 GS-7 G. sinense Pingguo, Guangxi, China
27 GS-8 G. sinense Liangshan, Shandong, China
28 GS-9 G. sinense Beijing, China
29 GS-10 G. sinense Jingzhou, Hunan, China
30 GS-11 G. sinense Jinzhai, Anhui, China
31 GS-12 G. sinense Jinzhai, Anhui, China
32 GS-13 G. sinense Macao, China
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quently re-dissolved in 1 mL n-hexane. The solution
was filtered through a 0.45 μm Econofilter (Agilent
Technologies, Palo Alto, CA, USA) before GC-MS
analysis.
GC-MS analysis
GC-MS was performed with an Agilent 6890 gas chro-
matography instrument coupled to an Agilent 5973
mass spectrometer and an Agilent ChemStation software
(Agilent Technologies, Palo Alto, CA). A capillary col-
umn (30 m × 0.25 mm i.d.) coated with 0.25 μmf i l m
5% phenyl methyl siloxane was used for separation.
High purity helium was used as carrier gas with flow-
rate at 1 ml·min
-1. The column temperature was set at
100°C and held for 5 min for injection, then pro-
g r a m m e da t2 0 ° Cm i n
-1 to 200°C and held for 10 min,
then at 10°C min
-1 to 230°C, and finally, at 5°C min
-1 to
320°C, and held for 5 min. Split injection (2 μL) with a
split ratio of 1:10 (or 1:100 if the content of analytes
beyond the upper limit of linearity ranges) was used,
and injection temperature was set at 260°C.
The spectrometers were operated in electron-impact
(EI) mode, the scan range was 40-550 amu, the ioniza-
tion energy was 70 eV and the scan rate was 0.34 s per
scan. The quadrupole, ionization source temperature
were 150°C and 280°C, respectively.
Calibration curves
Stock solutions containing 11 reference compounds
were prepared and diluted into appropriate concentra-
tions with n-hexane (Table 2) for the construction of
calibration curves using SIM mode of GC-MS, and the
fragment ions m/z 257, 285, 299, 313, 311, 341, 339,
337, 397, 425 and 363 were used for lauric acid (C12:0),
myristic acid (C14:0), pentadecanoic acid (C15:0),
palmitic acid (C16:0, PA), palmitoleic acid (C16:1), stea-
ric acid (C18:0, SA), oleic acid (C18:1, OA), linoleic acid
(C18:2, LoA), docosanoic acid (C22:0), lignoceric acid
(C24:0) and ergosterol, respectively. At least six concen-
trations of the solution were analyzed in duplicates, and
then the calibration curves were constructed by plotting
the peak area versus the amount (ng) of each analyte.
LOD and LOQ
Stock solution containing 11 reference compounds was
diluted to a series of appropriate concentrations with n-
hexane, and an aliquot of the diluted solutions was
injected into GC-MS for analysis. The limits of detec-
tion (LOD) and quantification (LOQ) under the present
chromatographic conditions were determined at the
ratio of signal to noise (S/N) equal to 3 and 10,
respectively.
Precision, repeatability and accuracy
Intra-day, inter-day variations were chosen to determine
the precision of the developed GC-MS assay. A certain
concentration (about at the middle of linear range) solu-
tion of 11 reference compounds was tested. For intra-
day variability, the samples were analyzed for six times
within one day, while for inter-day variability, the sam-
ples were examined in duplicate for consecutive three
days. Variations were expressed by the relative standard
deviations (RSD).
To test the repeatability of derivatization, PLE extract
of sample GL-1 was divided into three and respectively
derivatized under the optimum conditions then analyzed
by GC-MS as mentioned above. Variations were
expressed by RSD.
The recovery was used to evaluate the accuracy of
the method. Accurate amounts of individual standards
were added into a certain amount (0.1 g) of GL-1. The
Table 2 SIM, regression data, LOD, LOQ and recovery of 11 investigated compounds analyzed by GC-MS
Analytes SIM Linear regression data R
2 LOD
(ng)
LOQ
(ng)
Recovery
a
(%, n=3 )
Regressive Equation Linear range (ng)
Lauric acid 257 y = 55788x - 7172 0.2-4.7 0.9991 0.070 0.132 99.5
Myristic acid 285 y = 92491x - 9626 0.2-4.7 0.9994 0.039 0.073 99.9
Pentadecanoic acid 299 y = 100984x - 19569 0.3-8.6 0.9998 0.065 0.123 98.5
Palmitoieic acid 311 y = 107565x - 28765 0.4-11.8 0.9994 0.084 0.231 99.1
Palmitic acid 313 y = 13939x - 713 0.5-15.1 0.9990 0.064 0.118 101.4
Linoleic acid 337 y = 16543x - 9768 1.3-6.3 0.9982 0.220 0.413 101.3
Oleic acid 339 y = 36027x - 9874 0.4-7.0 0.9992 0.119 0.155 101.1
Stearic acid 341 y = 68023x - 67 0.3-37.7 0.9995 0.141 0.268 96.9
Docosanoic acid 397 y = 103013x - 88418 1.5-4.9 0.9990 0.485 0.971 100.2
Lignoceric acid 425 y = 103037x - 35337 0.6-9.3 0.9984 0.223 0.527 97.3
Ergosterol 363 y = 40732x - 6971 0.5-3.8 0.9989 0.251 0.471 101.9
a Recovery (%) = (amount found-original amount)/amount spiked.
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Figure 2 Typical TIC (Left) and SIM (Right) profiles of (A)mixed standards, (B) G. lucidum and (C) G. sinense determined by GC-MS. 1,
lauric acid; 2, myristic acid; 3, pentadecanoic acid; 4, palmitoleic acid; 5, palmitic acid; 6, linoleic acid; 7, oleic acid; 8, stearic acid; 9, docosanoic
acid; 10, lignoceric acid; 11, ergosterol.
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oped method. Three replicates were performed for the
test.
Data analysis
Hierarchical clustering analysis was performed by SPSS
18.0 for windows (SPSS Inc., Chicago, IL, USA), which
comprise a number of “procedures” graphical, statistical,
reporting, processing and tabulating procedures that
enable simple and rapid data evaluation. Hierarchical
cluster analysis was performed based on ergosterol and
ten fatty acids characteristics from GC-MS profiles of 32
tested samples, respectively. Ward’sm e t h o d ,av e r ye f f i -
cient method for the analysis of variance between
clusters was applied, and Euclidean Distance was
selected as measurement.
Result and discussion
Optimization of derivatization conditions
The derivatization conditions including derivatization
temperature (50, 70, 90°C) and the reaction time (30,
60, 90 min) for the investigated compounds were opti-
mized. On the other hand, the sufficient amount of deri-
vatization agent is necessary for good derivatization
efficiency. The amount of BSTFA (50, 100 and 200 μL)
were also investigated using univariate approach. Peak
area of each investigated compound in Ganoderma
extract was used as the marker for evaluation of the
Table 3 The contents (μg·g
-1) of ten investigated fatty acids and ergosterol in Ganoderma
Sample Code LA MA PtA PoA PA LoA OA SA DA LiA FAs ErS
GL-1 13.4
a 14.7 20.7 14.5 99.0 543.7 1116.9 77.4 27.9 50.3 1978.5 189.1
GL-2 17.0 19.3 51.7 41.1 331.2 1718.1 2953.6 177.9 26.7 37.6 5374.2 240.9
GL-3 20.2 16.9 27.1 22.4 149.3 988.8 1678.1 112.4 +
b 40.3 3055.5 578.5
GL-4 12.1 12.3 26.6 12.9 141.7 872.2 894.3 71.6 + 21.8 2065.5 846.7
GL-5 14.3 14.4 38.9 16.6 261.0 1323.0 1625.0 119.3 24.9 29.7 3467.1 681.1
GL-6 17.5 16.1 37.3 16.1 242.0 1742.4 1651.0 114.9 24.6 28.1 3889.9 703.5
GL-7 13.6 13.4 31.6 22.1 181.6 1028.2 1378.2 108.3 + 19.9 2796.9 553.8
GL-8 14.5 16.8 30.6 + 170.6 971.2 1324.9 118.2 28.4 36.6 2711.8 719.0
GL-9 18.8 15.2 29.1 14.9 146.3 753.7 971.7 85.9 + 19.2 2054.8 1278.5
GL-10 18.0 15.2 19.2 14.4 181.7 783.2 1533.6 166.2 46.4 51.0 2828.9 691.1
GL-11 13.8 17.2 42.7 16.5 272.7 1819.0 1881.9 141.7 24.5 36.8 4266.8 664.6
GL-12 16.2 16.4 22.6 16.1 119.9 819.2 1226.5 90.3 24.0 31.3 2382.6 740.2
GL-13 20.9 20.7 36.4 7.5 255.4 992.3 2143.0 150.1 44.6 62.7 3733.6 812.2
GL-14 16.4 13.5 16.9 + 86.6 338.1 333.9 91.6 + 19.2 916.1 881.4
GL-15 13.6 13.0 15.2 + 73.2 327.2 239.1 46.2 + 22.9 750.2 705.0
GL-16 28.6 28.2 61.9 25.9 213.0 2578.0 2817.6 61.9 + 30.3 5845.4 1029.2
GL-17 20.1 20.8 49.4 19.2 328.7 2567.1 2645.6 111.9 29.1 48.7 5840.6 615.8
GL-18 18.9 15.3 29.8 + 160.1 913.4 793.7 71.0 + 37.4 2039.6 1453.3
GL-19 19.0 13.5 25.2 7.5 134.6 916.5 353.2 62.0 + 18.4 1549.8 1256.8
GS-1 16.9 18.9 19.1 8.5 249.8 1524.1 2314.0 202.9 24.0 52.1 4430.5 91.6
GS-2 22.0 35.2 59.6 34.2 840.2 3555.3 4847.6 299.2 + 42.1 9735.3 17.3
GS-3 18.7 20.1 21.3 13.7 176.3 1047.7 1668.2 123.9 + 34.9 3124.7 80.1
GS-4 21.8 19.6 24.1 14.1 215.2 1328.7 1889.7 132.9 + 32.7 3678.7 104.6
GS-5 18.3 19.1 30.2 16.2 304.7 1464.6 1625.1 152.7 + 29.6 3660.5 344.2
GS-6 19.0 29.8 47.6 19.2 656.4 3559.5 4283.3 306.2 + 55.4 8976.3 43.5
GS-7 19.3 21.6 65.0 7.4 187.7 1974.6 295.3 58.0 + 13.9 2642.6 331.3
GS-8 19.8 39.6 65.3 25.7 950.1 3920.5 5611.4 391.4 + 53.1 11076.8 18.0
GS-9 25.7 36.1 46.3 18.9 479.8 2656.5 3447.8 222.9 + 38.4 6972.3 24.9
GS-10 15.3 15.3 21.2 + 119.8 839.2 465.2 67.6 + 18.5 1562.1 369.3
GS-11 22.9 33.1 76.9 28.2 765.8 2955.2 3719.4 198.9 + 40.7 7841.1 20.5
GS-12 22.0 37.3 55.7 32.2 775.2 3339.8 4706.9 283.7 + 45.0 9297.9 16.0
GS-13 16.0 19.9 42.4 8.2 360.9 2145.2 1723.2 96.5 + 26.1 4438.4 409.8
LA, lauric acid; MA, myristic acid; PtA, pentadecanoic acid; PoA, palmitoleic acid; PA, palmitic acid; LoA, linoleic acid; OA, oleic acid; SA, stearic acid; DA,
docosanoic acid; LiA, lignoceric acid; ErS, ergosterol; FAs: total content of ten fatty acids
a The data are presented as average of duplicates.
b Under the limit of quantification.
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tion conditions, which had highest efficiency in short
reaction time under mild temperature, were as follows:
100 μL BSTFA reacted with free sterol and fatty acids in
400 μL of n-hexane at 70°C for 30 min.
Validation of method
SIM method of GC-MS analysis for simultaneous inves-
tigation of the analytes was used for the quantification
and the fragment ions for simultaneous monitoring of
analytes were listed in Table 2.
All the calibration curves showed good linearity
within test ranges. The overall LODs and LOQs were
less than 0.485 ng and 0.971 ng, respectively (Table 2).
The optimized method showed good precision for the
quantification of 11 investigated components with
intra- and inter-day variations less than 2.7% and 4.3%,
and the repeatability of derivatization detected in PLE
extract of test sample (GL-1) was less than 3.2%. The
developed method also had good accuracy with overall
recovery of 96.9%-101.9% for the analytes (Table 2).
The results showed that the developed GC-MS method
was sensitive, precise and accurate for quantitative
determination of 11 investigated components in
Ganoderma.
Quantification of the investigated compounds in
Ganoderma by GC-MS
Typical TIC and SIM chromatograms of TMS derivatives
of mixture of 11 reference compounds and PLE extracts
of two species of Ganoderma w e r es h o w ni nF i g u r e2 .
The identification of investigated compounds was carried
out by comparison of their retention time and mass spec-
tra with those obtained by injecting standards in the
same conditions. By using the calibration curves of each
analyte, the contents (μg·g
-1) of ten fatty acids and one
sterol in Ganoderma were determined, which were sum-
marized in Table 3. The data showed that ergosterol, a
characteristic compound in fungi, was abundant in both
G. lucidum and G. sinense. PA, LOA, OA and SA were
the main fatty acids in Ganoderma, which were in accor-
dance to the results in G. lucidum spore [15].
Comparison of free sterol and fatty acids in two species
of Ganoderma
In China, G. lucidum and G. sinense is recorded as
Lingzhi in Chinese Pharmacopoeia. Ergosterol, as a spe-
cific component of fungal cell membrane, was also rich
in G. lucidum and G. sinense. But the content of ergos-
terol in G. lucidum (median content 705.0 μg·g
-1,r a n g e
189.1-1453.3 μg·g
-1, n = 19) was much higher than that
in G. sinense (median content 80.1 μg·g
-1, range 16.0-
409.8 μg·g
-1, n = 13), which is similar to triterpenoids
and polysaccharides [1,11,34]. However, it was much
lower than that reported before [11,35], which might
attribute to the different sample and/or peak overlap-
ping during HPLC analysis. Hierarchical clustering ana-
lysis based on the contents of ergosterol also showed
that 32 tested samples of Ganoderma were grouped into
two main clusters, G. lucidum and G. sinense,e x c e p t
two G. lucidum samples (Figure 3).
On the other hand, hierarchical clustering analysis
based on the contents of ten fatty acids was also per-
formed. The results showed that two species of Gano-
derma had no significant difference though two groups
were also obtained (Figure 3). Actually, the total content
GS-2
GS-8
GS-12
GS-9
GS-11
GS-6
GS-1
GS-3
GS-4
GL-1
GL-2
GS-5
GS-7
GS-10
GS-13
GL-9
GL-19
GL-18
GL-4
GL-13
GL-14
GL-16
GL-3
GL-7
GL-17
GL-5
GL-10
GL-11
GL-6
GL-15
GL-8
GL-12
I
II
++++++
0 5 10 15 20 25
Rescaled Distance Cluster Combine
GL-3
GS-3
GL-10
GL-7
GL-8
GL-12
GL-6
GL-11
GS-13
GL-5
GS-5
GS-4
GL-13
GS-1
GL-4
GL-18
GL-9
GL-1
GL-14
GL-15
GS-10
GL-19
GS-7
GS-2
GS-12
GS-6
GS-8
GS-9
GS-11
GL-16
GL-17
GL-2
++++++
0 5 10 15 20 25
Rescaled Distance Cluster Combine
I
II
A
B
Figure 3 Dendrograms of hierarchical cluster analysis resulting
from (A) ergosterol and (B) ten fatty acids in 32 tested
Ganoderma samples. GL1-GL19 and GS1-GS13 were same as in
Table 1.
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Page 6 of 8of fatty acids was higher in cluster II. Palmitic acid, lino-
leic acid, oleic acid and stearic acid were the main fatty
acids in Ganoderma, which were in accordance with the
previous reports for G. lucidum spore [15,36]. It was
reported that fatty acids from the spores of G. lucidum
could inhibit tumor cell proliferation. Nonadecanoic
acid (C19:0) showed the highest inhibitory activity, fol-
lowed by heptadecanoic acid (C17:0), stearic acid
(C18:0, SA) and palmitic acid (C16:0, PA) [20]. Actually,
saturated fatty acids including SA and PA are proapop-
totic agents [37]. Unsaturated fatty acids LoA and OA
have been revealed their anticancer activities [38-42] by
activating GPR40 [38] and inducing oxidant stress and
mitochondrial dysfunction [42] in cancer cell lines.
Therefore, the similarity of two species of Ganoderma
in fatty acids may be related to their antitumoral prolif-
eration effect.
Conclusion
The content of ergosterol is much higher in G. lucidum
than in G. sinense. Palmitic acid, linoleic acid, oleic acid,
stearic acid are main fatty acids in Ganoderma and their
content had no significant difference between G. luci-
dum and G. sinense, which may contribute to their anti-
tumoral proliferation effect.
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